检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张崇进[1] 徐文漭 唐一平[1] 雷德鸿 高翔[1] 赵宁辉[1] 付登礼[1] ZHANG Chong-jin;XU Wen-mang;TANG Yi-ping(The Second Department of Neurosurgery,the Second Affiliated Hospital of Kunming Medical University,Kunming 650101,China)
机构地区:[1]昆明医科大学第二附属医院神经外科二病区,昆明650101 [2]中国人民解放军联勤保障部队第920医院病理科
出 处:《临床神经外科杂志》2022年第1期105-108,共4页Journal of Clinical Neurosurgery
摘 要:目的探讨继发性胶质肉瘤的可能发病原因及诊断治疗。方法回顾性分析1例反复行胶质瘤切除并最终发展为继发性胶质肉瘤患者的临床资料,并对相关文献进行复习。结果患者,女,42岁,头部MRI显示左侧颞叶占位性病变;首次手术切除,术后病理诊断为间变性少突胶质细胞瘤(WHOⅢ级);术后第59个月发现右侧额叶占位病变,第二次手术切除,术后病理诊断为胶质母细胞瘤(WHO分级Ⅳ级),术后1个月行调强适形放射治疗+替莫唑胺化疗6个疗程;第二次术后31个月,患者右侧额叶肿瘤再次复发,第三次手术切除,术后病理诊断为胶质肉瘤(WHO分级Ⅳ级),第三次术后1个月调强适形放射(IMRT)治疗+威罗菲尼靶向治疗,随访12个月尚无临床症状。结论手术联合放化疗治疗及靶向治疗可能延迟胶质肉瘤患者的无进展生存期。Objective To investigate the possible causes,diagnosis and treatment of secondary gliosarcoma.Methods The clinical data of a patient who underwent repeated glioma resection and eventually developed into secondary gliosarcoma were analyzed retrospectively,and the relevant literature was reviewed.Results A 42 year old female patient presented with left temporal lobe space occupying on head MRI.The patient underwent the first surgical resection and was pathologically diagnosed as anaplasti coligodendroglioma(WHO gradeⅢ).59 months after operation,the right frontal lobe tumor was found and resected for the second time.The pathological diagnosis was glioblastoma(WHO gradeⅣ).Intensity modulated radiation therapy(IMRT)and temozolomide chemotherapy were performed 1 month after operation for 6 courses.31 months after the second operation,the tumor in the right frontal lobe recurred again and the third surgical resection was performed.The postoperative pathological diagnosis was gliosarcoma(WHO gradeⅣ).One month after the third operation,intensity modulated radiation therapy(IMRT)and targeted therapy with Vemurafenib was performed.The patient survived until now.Conclusion Surgery combined with chemo therapy,radiotherapy and targeted therapy may delay progression free survival in patients with gliosarcoma.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.22.242.214